Botulinum Toxin Therapy of Social Anxiety Disorder

Botulinum Toxin Therapy of Social Anxiety Disorder Letters to the Editors Journal of Clinical Psychopharmacology Volume 39, Number 4, July/August 2019 2. Stallman HM, Kohler M, Wilson A, et al. BT into the glabellar region between May DISCUSSION Self-reported sleepwalking in Australian senior 2017 and October 2018. None of the pa- Guanfacine may suppress rapid eye move- secondary school students. Sleep Med. tients had hyperhidrosis. In 5 patients, ment sleep, modulate sleep architecture, 2016;25:1–3. previous and current pharmacologic and and can result in less sleepwalking. As a se- 3. De Cock VC. Sleepwalking. Curr Treat Options psychotherapeutic treatments had either lective α-adrenergic 2A agonist, it has the Neurol. 2016;18:1–9. been insufficient or were discontinued ability to regulate glutamatergic and catechol- secondary to side effects. All patients 4. Stallman HM, Kohler M. A systematic amine systems, both implicated in the neuro- review of treatments for sleepwalking: were maintained on their existing treat- chemistry of sleepwalking. Benzodiazepines 100 years of case studies. Sleep Hypnosis. ment regimen, and written consent was lessen sleepwalking through a sedative- 2016;1–22. obtained. SAnD symptoms were assessed hypnotic effect. Antidepressant medications 5. Fredriksson I, Jayaram-Lindström N, Wirf M, by the Leibowitz Social Anxiety Scale are thought to decrease sleepwalking owing et al. Evaluation of http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Clinical Psychopharmacology Wolters Kluwer Health

Botulinum Toxin Therapy of Social Anxiety Disorder

Loading next page...
 
/lp/wolters-kluwer-health/botulinum-toxin-therapy-of-social-anxiety-disorder-a9eXGUtzhp
Publisher
Wolters Kluwer Health
Copyright
Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.
ISSN
0271-0749
eISSN
1533-712X
D.O.I.
10.1097/JCP.0000000000001066
Publisher site
See Article on Publisher Site

Abstract

Letters to the Editors Journal of Clinical Psychopharmacology Volume 39, Number 4, July/August 2019 2. Stallman HM, Kohler M, Wilson A, et al. BT into the glabellar region between May DISCUSSION Self-reported sleepwalking in Australian senior 2017 and October 2018. None of the pa- Guanfacine may suppress rapid eye move- secondary school students. Sleep Med. tients had hyperhidrosis. In 5 patients, ment sleep, modulate sleep architecture, 2016;25:1–3. previous and current pharmacologic and and can result in less sleepwalking. As a se- 3. De Cock VC. Sleepwalking. Curr Treat Options psychotherapeutic treatments had either lective α-adrenergic 2A agonist, it has the Neurol. 2016;18:1–9. been insufficient or were discontinued ability to regulate glutamatergic and catechol- secondary to side effects. All patients 4. Stallman HM, Kohler M. A systematic amine systems, both implicated in the neuro- review of treatments for sleepwalking: were maintained on their existing treat- chemistry of sleepwalking. Benzodiazepines 100 years of case studies. Sleep Hypnosis. ment regimen, and written consent was lessen sleepwalking through a sedative- 2016;1–22. obtained. SAnD symptoms were assessed hypnotic effect. Antidepressant medications 5. Fredriksson I, Jayaram-Lindström N, Wirf M, by the Leibowitz Social Anxiety Scale are thought to decrease sleepwalking owing et al. Evaluation of

Journal

Journal of Clinical PsychopharmacologyWolters Kluwer Health

Published: Jan 1, 2019

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create folders to
organize your research

Export folders, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off